Gene · 3803
Papers1,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,698
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population. | Innate Immun | 2023 | 37350049 | PubTator, text mining | PubMed |
| Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. | Cancers (Basel) | 2023 | 37345066 | PubTator, text mining | PubMed |
| A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G. | Front Immunol | 2023 | 37342325 | PubTator, text mining | PubMed |
| Identification of natural killer markers associated with fatal outcome in COVID-19 patients. | Front Cell Infect Microbiol | 2023 | 37342247 | PubTator, text mining | PubMed |
| Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML). | BMC Immunol | 2023 | 37340345 | PubTator, text mining | PubMed |
| Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. | J Ovarian Res | 2023 | 37322531 | PubTator, text mining | PubMed |
| Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1. | Cancer Commun (Lond) | 2023 | 37314951 | PubTator, text mining | PubMed |
| Editorial: NK cells in viral immunology and immunotherapy. | Front Immunol | 2023 | 37287980 | PubTator, text mining | PubMed |
| Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study. | J Clin Med | 2023 | 37240647 | PubTator, text mining | PubMed |
| Alterations in the CD56- and CD56+ T Cell Subsets during COVID-19. | Int J Mol Sci | 2023 | 37240393 | PubTator, text mining | PubMed |
| NK cell defects: implication in acute myeloid leukemia. | Front Immunol | 2023 | 37228595 | PubTator, text mining | PubMed |
| Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. | BMC Med | 2023 | 37226227 | PubTator, text mining | PubMed |
| Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real-world experience of a referral center. | EJHaem | 2023 | 37206286 | PubTator, text mining | PubMed |
| Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes. | Int J Mol Sci | 2023 | 37175450 | PubTator, text mining | PubMed |
| Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer. | Sci Rep | 2023 | 37169953 | PubTator, text mining | PubMed |
| Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data. | Genome Res | 2023 | 37169596 | PubTator, text mining | PubMed |
Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics. | Front Immunol | 2023 | 37138889 | PubTator, text mining | PubMed |
| KIR-HLA interactions extend human CD8+ T cell lifespan in vivo. | J Clin Invest | 2023 | 37071474 | PubTator, text mining | PubMed |
| Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells. | Front Immunol | 2023 | 37051244 | PubTator, text mining | PubMed |
| Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure. | Diagnostics (Basel) | 2023 | 37046435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3803/papers?page=6